TGen test shows promise for diagnosing Lyme / Arizona Daily Sun
Translational Genomics Research Institute in Flagstaff has seen promising initial results from a test it was asked to develop to diagnose Lyme disease, with plans now to use human blood samples to verify the accuracy of the process.
Scientists at TGen in Flagstaff have teamed up with researchers from Northern Arizona University to design a new test that would more accurately diagnose when someone has become infected with bacteria that may be antibiotic resistant. Read also: NAU, TGen develop faster MRSA test
California medtech manufacturer opening 500-job facility in Mesa / Phoenix Business Journal
Dexcom, a San Diego-based continuous glucose monitoring manufacturer, announced it will open a manufacturing plant in Mesa that could create up to 500 jobs.
Arizona Western College’s first high-school science camp in Yuma, funded by a Science Foundation Arizona grant, filled quickly which led to plans to offer the camp again next year.
Arizona heats things up at BIO 2016 / AZ Big Media (Op-ed)
Bioscience entrepreneur and investor Dirk Karsten Beth reports that Arizona had an impressive showing at the annual BIO International Convention and received new commitments to attend the White Hat Investors Conference in Phoenix in September.
Smart Brain Aging win in Innovation Challenge brings up conflict of interest issues / Phoenix Business Journal
For the second time, a company belonging to a past volunteer judge in the Arizona Innovation Challenge—this time, Smart Brain Aging— has been awarded one of the $250,000 prizes, but the Arizona Commerce Authority says it has procedures in place to prevent conflict-of-interest issues.
Walgreens shuts down 40 Theranos centers in Arizona / Arizona Republic
Walgreens Co. has closed all 40 Theranos Wellness Center locations in metro Phoenix, cutting the California-based blood-testing company’s retail footprint in Arizona to four locations.
Here is Arizona’s most active tech venture-capital firm / Phoenix Business Journal
With its $13 million early-stage seed fund, Scottsdale’s Tallwave Capital has been named Arizona’s most active tech venture-capital firm by New York-based CB Insights.